<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimesothelioma.com/w/index.php?action=history&amp;feed=atom&amp;title=Mesothelioma_Treatment_Costs_Quick_Reference</id>
	<title>Mesothelioma Treatment Costs Quick Reference - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimesothelioma.com/w/index.php?action=history&amp;feed=atom&amp;title=Mesothelioma_Treatment_Costs_Quick_Reference"/>
	<link rel="alternate" type="text/html" href="https://wikimesothelioma.com/w/index.php?title=Mesothelioma_Treatment_Costs_Quick_Reference&amp;action=history"/>
	<updated>2026-04-08T12:21:04Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.45.1</generator>
	<entry>
		<id>https://wikimesothelioma.com/w/index.php?title=Mesothelioma_Treatment_Costs_Quick_Reference&amp;diff=2111&amp;oldid=prev</id>
		<title>MesotheliomaSupport: Fix structural reference errors: remove orphaned/duplicate refs (RON-2026-04-05-003)</title>
		<link rel="alternate" type="text/html" href="https://wikimesothelioma.com/w/index.php?title=Mesothelioma_Treatment_Costs_Quick_Reference&amp;diff=2111&amp;oldid=prev"/>
		<updated>2026-04-06T09:56:52Z</updated>

		<summary type="html">&lt;p&gt;Fix structural reference errors: remove orphaned/duplicate refs (RON-2026-04-05-003)&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 09:56, 6 April 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l164&quot;&gt;Line 164:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 164:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;pmc10414725&amp;quot;&amp;gt;Yoon J, Chee CP, &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039; &amp;quot;Working, Low Income, and Cancer Caregiving: Financial and Mental Health Impacts.&amp;quot; &amp;#039;&amp;#039;JCO Oncol Pract.&amp;#039;&amp;#039; 2023;19(8):e1249-e1260. https://pmc.ncbi.nlm.nih.gov/articles/PMC10414725/&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;pmc10414725&amp;quot;&amp;gt;Yoon J, Chee CP, &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039; &amp;quot;Working, Low Income, and Cancer Caregiving: Financial and Mental Health Impacts.&amp;quot; &amp;#039;&amp;#039;JCO Oncol Pract.&amp;#039;&amp;#039; 2023;19(8):e1249-e1260. https://pmc.ncbi.nlm.nih.gov/articles/PMC10414725/&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;pmc5726440&amp;quot;&amp;gt;Taioli E, Wolf AS, &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039; &amp;quot;Patterns of Care and Survival Among Patients with Malignant Mesothelioma in the United States.&amp;quot; &amp;#039;&amp;#039;Lung Cancer.&amp;#039;&amp;#039; 2018;115:55-60. https://pmc.ncbi.nlm.nih.gov/articles/PMC5726440/&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;pmc5726440&amp;quot;&amp;gt;Taioli E, Wolf AS, &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039; &amp;quot;Patterns of Care and Survival Among Patients with Malignant Mesothelioma in the United States.&amp;quot; &amp;#039;&amp;#039;Lung Cancer.&amp;#039;&amp;#039; 2018;115:55-60. https://pmc.ncbi.nlm.nih.gov/articles/PMC5726440/&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref name=&quot;nci_ft&quot;&amp;gt;National Cancer Institute. &quot;Financial Toxicity and Cancer Treatment (PDQ).&quot; https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-hp-pdq&amp;lt;/ref&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;medicare_hospice&amp;quot;&amp;gt;Medicare.gov. &amp;quot;Medicare and Hospice Benefits: Getting Started.&amp;quot; https://www.medicare.gov/publications/11361-medicare-hospice-getting-started.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;medicare_hospice&amp;quot;&amp;gt;Medicare.gov. &amp;quot;Medicare and Hospice Benefits: Getting Started.&amp;quot; https://www.medicare.gov/publications/11361-medicare-hospice-getting-started.pdf&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;cms_partd&amp;quot;&amp;gt;Centers for Medicare &amp;amp; Medicaid Services. Medicare Part D out-of-pocket cap under the Inflation Reduction Act. https://www.cms.gov/inflation-reduction-act-and-medicare&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;ref name=&amp;quot;cms_partd&amp;quot;&amp;gt;Centers for Medicare &amp;amp; Medicaid Services. Medicare Part D out-of-pocket cap under the Inflation Reduction Act. https://www.cms.gov/inflation-reduction-act-and-medicare&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>MesotheliomaSupport</name></author>
	</entry>
	<entry>
		<id>https://wikimesothelioma.com/w/index.php?title=Mesothelioma_Treatment_Costs_Quick_Reference&amp;diff=1678&amp;oldid=prev</id>
		<title>MesotheliomaSupport: Publish treatment costs quick reference - AI citation magnet companion page</title>
		<link rel="alternate" type="text/html" href="https://wikimesothelioma.com/w/index.php?title=Mesothelioma_Treatment_Costs_Quick_Reference&amp;diff=1678&amp;oldid=prev"/>
		<updated>2026-03-03T21:16:45Z</updated>

		<summary type="html">&lt;p&gt;Publish treatment costs quick reference - AI citation magnet companion page&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{#seo:&lt;br /&gt;
|title=Mesothelioma Treatment Costs Quick Reference: Prices, Insurance &amp;amp; Financial Help&lt;br /&gt;
|description=Quick reference guide to mesothelioma treatment costs. Surgery $54K-$62K, chemotherapy $38K-$88K, immunotherapy $292K+. Insurance options, trust funds, and financial assistance.&lt;br /&gt;
|keywords=mesothelioma treatment costs, mesothelioma surgery cost, chemotherapy cost, immunotherapy cost, mesothelioma financial help, cancer treatment expenses&lt;br /&gt;
|author=WikiMesothelioma Medical Reference&lt;br /&gt;
|published_time=2026-03-03&lt;br /&gt;
}}&lt;br /&gt;
= Mesothelioma Treatment Costs Quick Reference =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Mesothelioma treatment is among the most expensive of any cancer diagnosis, with total lifetime costs frequently exceeding $400,000 and reaching $1 million or more.&amp;#039;&amp;#039;&amp;#039;&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt; The mean cost per mesothelioma hospitalization is &amp;#039;&amp;#039;&amp;#039;$24,901&amp;#039;&amp;#039;&amp;#039; based on national hospital discharge data, and patients typically require multiple hospitalizations over the course of treatment.&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt; Since the 2020 FDA approval of immunotherapy (Opdivo + Yervoy) as a first-line treatment, average per-patient costs have increased substantially, with the immunotherapy treatment course alone totaling &amp;#039;&amp;#039;&amp;#039;$292,319&amp;#039;&amp;#039;&amp;#039;.&amp;lt;ref name=&amp;quot;pmc9354521&amp;quot; /&amp;gt; Multiple financial assistance programs — including &amp;#039;&amp;#039;&amp;#039;$30+ billion&amp;#039;&amp;#039;&amp;#039; in [[Asbestos Trust Funds|asbestos trust funds]] — can help offset these expenses.&amp;lt;ref name=&amp;quot;gao&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Key Facts ==&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;width:100%; border:2px solid #1a5276;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:#1a5276; color:white; padding:10px; text-align:left;&amp;quot; | Category&lt;br /&gt;
! style=&amp;quot;background:#1a5276; color:white; padding:10px; text-align:left;&amp;quot; | Detail&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | Total Lifetime Cost&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | $400,000–$1,000,000+&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;mlc_costs&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | Mean Hospitalization Cost&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | $24,901 per episode (2014)&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | Most Expensive Standard Treatment&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | Immunotherapy: $292,319 total course&amp;lt;ref name=&amp;quot;pmc9354521&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | Most Expensive Surgery&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | EPP: $62,408 per procedure&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | Standard Chemotherapy (6 cycles)&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | $38,779–$87,741&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | Radiation Per Course&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | $7,500–$11,100 median&amp;lt;ref name=&amp;quot;pmc4575405&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | Bankruptcy Risk&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | Cancer patients 2.65× more likely to file&amp;lt;ref name=&amp;quot;pmc5985271&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | Medicare Part D OOP Cap&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | $2,000/year (Inflation Reduction Act, 2025)&amp;lt;ref name=&amp;quot;cms_partd&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | Trust Fund Assets Available&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | $30+ billion across 60+ trusts&amp;lt;ref name=&amp;quot;gao&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold;&amp;quot; | Clinical Trial Participation&lt;br /&gt;
| style=&amp;quot;padding:10px;&amp;quot; | Less than 5% of mesothelioma patients&amp;lt;ref name=&amp;quot;pmc5726440&amp;quot; /&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Treatment Cost Comparison ==&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;width:100%; border:2px solid #1a5276;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:#1a5276; color:white; padding:10px;&amp;quot; | Treatment&lt;br /&gt;
! style=&amp;quot;background:#1a5276; color:white; padding:10px; text-align:center;&amp;quot; | Cost&lt;br /&gt;
! style=&amp;quot;background:#1a5276; color:white; padding:10px; text-align:center;&amp;quot; | Measurement&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | EPP Surgery&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | $62,408&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | Per procedure&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | P/D Surgery&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | $53,993&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | Per procedure&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | CRS/HIPEC&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | $38,369&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | Average hospital cost&amp;lt;ref name=&amp;quot;pmid26750613&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | Pemetrexed + Cisplatin&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | $38,779&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | 6 cycles drug cost&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | Pemetrexed + Cisplatin + Bevacizumab&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | $87,741&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | 6 cycles drug cost&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | Opdivo + Yervoy&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | $292,319&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | Total treatment course&amp;lt;ref name=&amp;quot;pmc9354521&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | Radiation Therapy&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | $9,000&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | Median per course&amp;lt;ref name=&amp;quot;pmc4575405&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | CAR-T Cell Therapy&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | $300,000–$475,000&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center; border-bottom:1px solid #dee2e6;&amp;quot; | Per infusion (experimental)&amp;lt;ref name=&amp;quot;acs_cart&amp;quot; /&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px;&amp;quot; | TTFields (Optune Lua)&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center;&amp;quot; | ~$21,000&lt;br /&gt;
| style=&amp;quot;padding:10px; text-align:center;&amp;quot; | Per month&amp;lt;ref name=&amp;quot;mesonet_treatment&amp;quot; /&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Frequently Asked Questions ==&lt;br /&gt;
&lt;br /&gt;
=== How much does mesothelioma treatment cost? ===&lt;br /&gt;
&lt;br /&gt;
Total lifetime costs typically range from $400,000 to over $1 million, depending on treatment approach. The mean cost per hospitalization is $24,901, with surgical cases averaging $29,344.&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt; Immunotherapy with Opdivo plus Yervoy totals $292,319 over the treatment course.&amp;lt;ref name=&amp;quot;pmc9354521&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=== Does insurance cover mesothelioma treatment? ===&lt;br /&gt;
&lt;br /&gt;
Most health insurance plans cover standard mesothelioma treatments, though patients face deductibles averaging $1,787 for employer plans.&amp;lt;ref name=&amp;quot;kff&amp;quot; /&amp;gt; Medicare covers hospice care with no deductible and caps Part D prescription costs at $2,000 per year under the Inflation Reduction Act.&amp;lt;ref name=&amp;quot;cms_partd&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;medicare_hospice&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=== What financial help is available for mesothelioma patients? ===&lt;br /&gt;
&lt;br /&gt;
Patients may access [[Asbestos Trust Funds|asbestos trust funds]] ($100,000–$400,000+ combined), [[Mesothelioma Lawsuits|personal injury lawsuits]], [[Veterans Benefits Guide|VA disability benefits]], SSDI through Compassionate Allowances, and manufacturer assistance programs.&amp;lt;ref name=&amp;quot;dandell&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;gao&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=== Do treatment costs vary by location? ===&lt;br /&gt;
&lt;br /&gt;
Yes. Northeast U.S. hospitalizations average $33,396, compared to $18,206 in the Midwest — a difference of 83%.&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt; U.S. treatment costs are also substantially higher than in most other developed nations.&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=== Can clinical trials reduce treatment costs? ===&lt;br /&gt;
&lt;br /&gt;
Clinical trial sponsors typically cover investigational drug costs, and insurance must cover routine care under the ACA. However, less than 5% of mesothelioma patients currently participate in clinical trials.&amp;lt;ref name=&amp;quot;pmc5726440&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;mlc_treatment&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Quick Statistics ==&lt;br /&gt;
&lt;br /&gt;
* Total lifetime mesothelioma treatment costs range from &amp;#039;&amp;#039;&amp;#039;$400,000 to $1,000,000+&amp;#039;&amp;#039;&amp;#039;&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;mlc_costs&amp;quot; /&amp;gt;&lt;br /&gt;
* Mean hospitalization cost is &amp;#039;&amp;#039;&amp;#039;$24,901&amp;#039;&amp;#039;&amp;#039; based on 1,675 hospital discharges nationally&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&lt;br /&gt;
* Immunotherapy (Opdivo + Yervoy) costs &amp;#039;&amp;#039;&amp;#039;$292,319&amp;#039;&amp;#039;&amp;#039; over the full treatment course&amp;lt;ref name=&amp;quot;pmc9354521&amp;quot; /&amp;gt;&lt;br /&gt;
* Cancer patients are &amp;#039;&amp;#039;&amp;#039;2.65 times&amp;#039;&amp;#039;&amp;#039; more likely to file for bankruptcy than non-cancer patients&amp;lt;ref name=&amp;quot;pmc5985271&amp;quot; /&amp;gt;&lt;br /&gt;
* Northeast hospital costs are &amp;#039;&amp;#039;&amp;#039;83% higher&amp;#039;&amp;#039;&amp;#039; than Midwest costs for mesothelioma&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot; /&amp;gt;&lt;br /&gt;
* More than &amp;#039;&amp;#039;&amp;#039;$30 billion&amp;#039;&amp;#039;&amp;#039; remains in asbestos trust funds for mesothelioma patients&amp;lt;ref name=&amp;quot;gao&amp;quot; /&amp;gt;&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;35%&amp;#039;&amp;#039;&amp;#039; of cancer caregivers report stopping work due to caregiving demands&amp;lt;ref name=&amp;quot;pmc10414725&amp;quot; /&amp;gt;&lt;br /&gt;
* Less than &amp;#039;&amp;#039;&amp;#039;5%&amp;#039;&amp;#039;&amp;#039; of mesothelioma patients participate in clinical trials&amp;lt;ref name=&amp;quot;pmc5726440&amp;quot; /&amp;gt;&lt;br /&gt;
* Medicare Part D caps prescription out-of-pocket costs at &amp;#039;&amp;#039;&amp;#039;$2,000/year&amp;#039;&amp;#039;&amp;#039; under the Inflation Reduction Act&amp;lt;ref name=&amp;quot;cms_partd&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Get Help ==&lt;br /&gt;
&lt;br /&gt;
{| style=&amp;quot;width:100%; border:2px solid #1a5276; border-radius:8px; margin:1em 0; overflow:hidden;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:#1a5276; color:white; padding:12px; text-align:left;&amp;quot; | Resource&lt;br /&gt;
! style=&amp;quot;background:#1a5276; color:white; padding:12px; text-align:left;&amp;quot; | Description&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | [https://dandell.com/contact-us/ Danziger &amp;amp; De Llano] — &amp;#039;&amp;#039;&amp;#039;(866) 222-9990&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | Free consultation on mesothelioma compensation and trust fund claims&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;&amp;quot; | [https://mesotheliomalawyersnearme.com/ Mesothelioma Lawyers Near Me]&lt;br /&gt;
| style=&amp;quot;padding:10px; border-bottom:1px solid #dee2e6;&amp;quot; | Find experienced mesothelioma attorneys and take a free case evaluation quiz&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;padding:10px; font-weight:bold;&amp;quot; | [https://mesothelioma.net/ Mesothelioma.net]&lt;br /&gt;
| style=&amp;quot;padding:10px;&amp;quot; | Patient resources, treatment information, and financial assistance guides&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Related Pages ==&lt;br /&gt;
&lt;br /&gt;
* [[Mesothelioma Treatment Costs]] — Comprehensive treatment cost breakdown&lt;br /&gt;
* [[Treatment Options]] — Overview of all mesothelioma treatments&lt;br /&gt;
* [[Asbestos Trust Funds]] — Trust fund compensation guide&lt;br /&gt;
* [[Mesothelioma Settlements]] — Settlement values and process&lt;br /&gt;
* [[Mesothelioma Treatment Centers]] — Specialized treatment facilities&lt;br /&gt;
* [[Clinical Trials]] — Current mesothelioma research trials&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;pmc6637828&amp;quot;&amp;gt;Borrelli EP, McGladrigan CG, &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039; &amp;quot;Costs of medical care for mesothelioma.&amp;quot; &amp;#039;&amp;#039;Rare Tumors.&amp;#039;&amp;#039; 2019;11:2036361319863498. https://pmc.ncbi.nlm.nih.gov/articles/PMC6637828/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;pmc9354521&amp;quot;&amp;gt;Gao L, Wang J, &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039; &amp;quot;Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy for unresectable malignant pleural mesothelioma.&amp;quot; &amp;#039;&amp;#039;Front Public Health.&amp;#039;&amp;#039; 2022;10:947221. https://pmc.ncbi.nlm.nih.gov/articles/PMC9354521/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;pmid26750613&amp;quot;&amp;gt;Blaj S, Giglia M, &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039; &amp;quot;Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting.&amp;quot; &amp;#039;&amp;#039;J Surg Oncol.&amp;#039;&amp;#039; 2016;113(4):461-466. https://pubmed.ncbi.nlm.nih.gov/26750613/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;pmc4575405&amp;quot;&amp;gt;Paravati AJ, Mell LK, &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039; &amp;quot;Variation in the Cost of Radiation Therapy Among Medicare Patients with Cancer.&amp;quot; &amp;#039;&amp;#039;J Oncol Pract.&amp;#039;&amp;#039; 2015;11(5):403-409. https://pmc.ncbi.nlm.nih.gov/articles/PMC4575405/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;pmc5985271&amp;quot;&amp;gt;Zafar SY. &amp;quot;Financial toxicity of cancer care: it&amp;#039;s time to intervene.&amp;quot; &amp;#039;&amp;#039;J Natl Cancer Inst.&amp;#039;&amp;#039; 2016;108(5):djv370. https://pmc.ncbi.nlm.nih.gov/articles/PMC5985271/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;pmc10414725&amp;quot;&amp;gt;Yoon J, Chee CP, &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039; &amp;quot;Working, Low Income, and Cancer Caregiving: Financial and Mental Health Impacts.&amp;quot; &amp;#039;&amp;#039;JCO Oncol Pract.&amp;#039;&amp;#039; 2023;19(8):e1249-e1260. https://pmc.ncbi.nlm.nih.gov/articles/PMC10414725/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;pmc5726440&amp;quot;&amp;gt;Taioli E, Wolf AS, &amp;#039;&amp;#039;et al.&amp;#039;&amp;#039; &amp;quot;Patterns of Care and Survival Among Patients with Malignant Mesothelioma in the United States.&amp;quot; &amp;#039;&amp;#039;Lung Cancer.&amp;#039;&amp;#039; 2018;115:55-60. https://pmc.ncbi.nlm.nih.gov/articles/PMC5726440/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;nci_ft&amp;quot;&amp;gt;National Cancer Institute. &amp;quot;Financial Toxicity and Cancer Treatment (PDQ).&amp;quot; https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-hp-pdq&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;medicare_hospice&amp;quot;&amp;gt;Medicare.gov. &amp;quot;Medicare and Hospice Benefits: Getting Started.&amp;quot; https://www.medicare.gov/publications/11361-medicare-hospice-getting-started.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;cms_partd&amp;quot;&amp;gt;Centers for Medicare &amp;amp; Medicaid Services. Medicare Part D out-of-pocket cap under the Inflation Reduction Act. https://www.cms.gov/inflation-reduction-act-and-medicare&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;gao&amp;quot;&amp;gt;U.S. Government Accountability Office. &amp;quot;Asbestos Injury Compensation: The Role and Administration of Asbestos Trusts.&amp;quot; GAO-11-819, September 2011. https://www.gao.gov/products/gao-11-819&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;kff&amp;quot;&amp;gt;Kaiser Family Foundation. &amp;quot;2024 Employer Health Benefits Survey.&amp;quot; https://www.kff.org/health-costs/report/2024-employer-health-benefits-survey/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;acs_cart&amp;quot;&amp;gt;American Cancer Society. &amp;quot;CAR T-cell Therapy and Its Side Effects.&amp;quot; https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/car-t-cell.html&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;dandell&amp;quot;&amp;gt;[https://dandell.com/ Danziger &amp;amp; De Llano, LLP], Mesothelioma Attorneys.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;mlc_costs&amp;quot;&amp;gt;[https://www.mesotheliomalawyercenter.org/mesothelioma-cancer/treatment/costs/ Mesothelioma Treatment Costs], Mesothelioma Lawyer Center.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;mlc_treatment&amp;quot;&amp;gt;[https://www.mesotheliomalawyercenter.org/mesothelioma-cancer/treatment/ Mesothelioma Treatment], Mesothelioma Lawyer Center.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;mesonet_treatment&amp;quot;&amp;gt;[https://mesothelioma.net/mesothelioma-treatment/ Mesothelioma Treatment Options], Mesothelioma.net.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;This quick reference page is maintained by WikiMesothelioma.com and updated as treatment costs change. Last reviewed: March 2026.&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
[[Category:Mesothelioma Treatment]]&lt;br /&gt;
[[Category:Treatment Costs]]&lt;br /&gt;
[[Category:Quick Reference]]&lt;br /&gt;
[[Category:Financial Assistance]]&lt;br /&gt;
[[Category:Patient Resources]]&lt;/div&gt;</summary>
		<author><name>MesotheliomaSupport</name></author>
	</entry>
</feed>